| content |
| Type | Public |
|---|---|
| Headquarters | Vancouver, British Columbia, Canada |
| Key people | Dr. William L. Hunter, M.D. |
| Industry | Pharmaceutical |
| Market cap | 43 million USD1 |
| Employees | 351 |
| Website | www.angiotech.com |
Angiotech (TSX: ANP) is a Vancouver, British Columbia pharmaceutical company. Its products enhance the performance of medical devices and biomaterials through the use of pharmacotherapeutics. Angiotech is a global specialty pharmaceutical and medical device company that discovers, develops, and markets innovative technologies and medical products primarily for local diseases or for complications associated with medical device implants, surgical interventions and acute injury. The company is listed on both the TSX and NASDAQ stock exchanges (NASDAQ: ANPI, TSX: ANP).
References
- ^ a b "Company Profile for Angiotech Pharmaceuticals Inc (CA;ANP)". Retrieved on 2008-10-10.
External links
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
| This article about a Canadian corporation or company is a stub. You can help Wikipedia by expanding it. |
